18F-fluoro-2-deoxy-D-glucose–positron emission tomography (PET)/PET-computed tomography in carcinoma of the cervix

Authors

  • Rakesh Kumar MD,

    1. Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India
    Search for more papers by this author
  • Simin Dadparvar MD

    Corresponding author
    1. Division of Nuclear Medicine, Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
    • Division of Nuclear Medicine, Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA 19104
    Search for more papers by this author
    • Fax: (215) 349-5843


  • See referenced original article on pages 1738–44, this issue.

Abstract

18F-fluoro-2-deoxy-D-glucose–positron emission tomography (FDG-PET)/PET-computed tomography diagnostic studies may play a potential role in the staging and restaging of patients with cervical cancer. Recent work has demonstrated another important aspect of FDG-PET in predicting the prognosis for patients with cervical cancer according to their maximal standard uptake value at baseline; thus, it may be possible to develop more aggressive treatment strategies for high-risk patients based on pretreatment PET studies.

Ancillary